GSK Investigational Site

Oakville, Ontario L6M 1M1

0 studies enrolling now · 14 studies all time

What they study most

Atherosclerosis, Dermatitis, Atopic, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Incontinence, Urinary and Urinary Bladder, Overactive, Neoplasms, Prostate, Overactive Bladder, Prostatic Hyperplasia, Psoriasis

Studies at this site

• Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus — Completed
• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) — Completed
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis — Completed
• Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
• Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy — Completed
• A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder — Completed
• Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• SB-480848 In Subjects With Coronary Heart Disease — Completed